Benzalkonium chloride induced bronchoconstriction in patients with stable bronchial asthma

Korean Journal of Internal Medicine

Volumn 22, Issue 4, 2007, Pages 244-248

  Lee, Byoung Hoon ^a   Kim, Sang Hoon ^a  

^a Eulji General Hospital   (South Korea)

Author keywords

Asthma; Benzalkonium chloride; Bronchoconstriction

Indexed keywords

BENZALKONIUM CHLORIDE; SALBUTAMOL; BENZALKONIUM; DETERGENT;

ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DRUG SAFETY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; KOREA; MALE; PROVOCATION TEST; THORAX PAIN; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; HEALTH SURVEY; INHALATION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; SPIROMETRY;

ADULT; ALBUTEROL; ASTHMA; BENZALKONIUM COMPOUNDS; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; CASE-CONTROL STUDIES; DETERGENTS; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SPIROMETRY;

EID: 43049093422     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2007.22.4.244     Document Type: Article

References (13)

1. Purohit A, Kopferschmitt-Kubler MC, Moreau C, Popin E, Blaumeiser M, Pauli G. Quaternary ammonium compounds and occupational asthma. Int Arch Occup Environ Health 73:423-427, 2000
2. Bernstein JA, Stauder T, Bernstein DI, Bernstein IL. A combined respiratory and cutaneous hypersensitivity syndrome induced by work exposure to quaternary amines. J Allergy Clin Immunol 94:257-259, 1994
3. Beasley CR, Rafferty P, Holgate ST. Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution. Br Med J 294:1197-1198, 1987
4. Asmus MJ, Barros MD, Liang J, Chesrown SE, Hendeles L. Pulmonary function response to EDTA, an additive in nebulized bronchodilators. J Allergy Clin Immunol 107:68-72, 2001
5. Asmus MJ, Sherman J, Hendeles L. Bronchoconstrictor additives in bronchodilator solutions. J Allergy Clin Immunol 104:S53-S60, 1999
6. Zhang YG, Wright WJ, Tam WK, Nguyen-Dang TH, Salome CM, Woolcock AJ. Effect of inhaled preservatives on asthmatic subjects: II. benzalkonium chloride. Am Rev Respir Dis 141:1405-1408, 1990
7. Boucher M, Roy MT, Henderson J. Possible association of benzalkonium chloride in nebulizer solutions with respiratory arrest. Ann Pharmacother 26:772-774, 1992
8. Beasley R, Burgess C, Holt S. Call for worldwide withdrawal of benzalkonium chloride from nebulizer solutions. J Allergy Clin Immunol 107:222-223, 2001
9. Read GW, Kiefer EF. Benzalkonium chloride: selective inhibitor of histamine release induced by compound 48/80 and other polyamines. J Pharmacol Exp Ther 211:711-715, 1979
10. Kim SH, Ahn Y. Anaphylaxis caused by benzalkonium in a nebulizer solution. J Korean Med Sci 19:289-290, 2004
11. Miszkiel KA, Beasley R, Rafferty P, Holgate ST. The contribution of histamine release to bronchoconstriction provoked by inhaled benzalkonium chloride in asthma. Br J Clin Pharmacol 25:157-163, 1988
12. Patel KR, Pavia D, Lowe L, Spiteri M. Inhaled ethanolic and aqueous solutions via Respimat Soft Mist Inhaler are well-tolerated in asthma patients. Respiration 73:434-440, 2006
13. Global Initiative for Asthma Management and Prevention. NHLB/WHO workshop report. No.95. p. 3659, National Bethesda, Institutes of Health, 1995